Rare diseases
Investigational molecules
Locations
Study on Switching to Islatravir and MK-8507 for Adults with HIV-1 Who Are Virologically Suppressed on a Drug Combination
FranceStudy on Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Patients with Good Control and Neuropsychiatric Concerns
SpainStudy Comparing Bictegravir/Lenacapavir to Current Therapy in People with HIV-1 Who Are Successfully Treated
FranceStudy Comparing Integrase Inhibitor (Bictegravir) and Boosted Protease Inhibitor (Darunavir) Treatments for Patients with Advanced HIV Infection
BelgiumStudy on Switching HIV Treatment to Dolutegravir/Lamivudine in Patients Aged 50+ with Virologic Suppression
AustriaStudy Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in Adults New to Antiretroviral Therapy
BelgiumStudy Comparing Bictegravir and Lenacapavir to Current Treatment in Patients with HIV-1 on Complex Regimens
FranceStudy Comparing Two Drug Regimens for HIV: Lamivudine and Dolutegravir Sodium vs. Emtricitabine, Tenofovir Alafenamide, and Bictegravir in HIV-Positive Patients
BelgiumStudy on the Effects of Abacavir Sulfate and Etravirine in Pregnant Women with HIV
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
